Clinical Trial Update: Role of Interleukin-1β and Prostaglandin E2 in Prediction and Outcome of Apnea in Neonates

View source ↗

Summary

A completed clinical trial investigates whether interleukin-1β and prostaglandin E2 can predict apnea and influence its outcomes in premature neonates (28–33 we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Snippet

Sponsor: Benha University | Conditions: Premature Newborns, Premature Newborns With Gestational Age 28 to 33 Weeks | Status: COMPLETED